US foreign aid cuts pressure health systems in emerging markets

At least 38% of USAID funds have been cut compared to FY 2024-25.

Ongoing cuts in foreign funding from developed countries will increase pressure on health systems in emerging markets, negatively impacting emergency preparedness and the delivery of services and medical products, according to a BMI report.

The US, through agencies such as USAID, has historically been the largest donor for global health programmes, including efforts to combat HIV, malaria, and tuberculosis in low and middle-income countries.

“Since President Trump took office on 20 January, at least 38% of USAID funds have been cut compared to FY 2024-25 obligations, according to the Center For Global Development,” the report said.

Specifically, funding for HIV prevention and treatment has been reduced by 20%, whilst funds for malaria control have been cut by 36%.

Furthermore, programmes addressing reproductive, maternal, and child health have faced cuts exceeding 95%.

“We anticipate continued disruptions in the supply and procurement of healthcare products, including HIV antiretrovirals, pre-exposure prophylaxis, anti-malaria drugs, routine immunisations and diagnostic tests,” it added.